Background: Deep brain stimulation (DBS) is used as symptomatic treatment of tremor in several movement disorders. We report the findings of a retrospective study of all patients with non-Parkinson disease (PD) non dystonic tremor receiving DBS in the ventral intermedate nucleus of thalamus (VIM) at Oslo University hospital- Rikshospitalet from 1996 to 2010 with analysis of survival, mortality, adverse effects, patient satisfaction and self-reported effect of VIM-DBS. Methods: Retrospective study including 53 patients. Data obtained from patients records and an 18-item questionarie including VAS scale. SPSS used for statistical analysis. P-value < 0.05 considered statistically significant. Results: Of 53 included patients there were 32 (60,4%) men and 21 (39,6 %) women. 46 patients were diagnosed with ET. The other 7 patients had symptomatic tremor conditions: cerebellar tremor (2), cerebellar tremor in MS (1) Holmes tremor (1) and action tremor after vascular ischaemic lesions in the posterior fossa (3). Mean age at operation was 60.9 years. 9 patients (17 %) died during the study period. Mean age at death was 75.3 years and mean time from surgery until death was 7.7 years. There were no significant increase in mortality. The patients reported high satisfaction with VIM-DBS together with a good effect on tremor at long term follow up. Adverse effects were generally well tolerated. Conclusions: We conclude that VIM-DBS is a safe symptomatic treatment of non-PD non dystonic tremor conditions with a long-term effect on tremor.